Qlucore, a developer of bioinformatics software, is expanding into the area of precision medicine and precision diagnostics.

LabCorp has announced that it will adopt Thermo Fisher Scientific’s Ion Torrent Genexus System and Oncomine Precision Assay for use in research and development of companion diagnostics.

Researchers have identified two major genes associated with bovine congestive heart failure, and consequently developed a genetic test that could be used to inform selective breeding.

Oxford Gene Technology (OGT), has announced the launch of its SureSeq CLL + CNV Panel — the company’s latest next-generation sequencing offering for research into Chronic Lymphocytic Leukaemia.

ERS Genomics has announced the signing of a license agreement with Daiichi Sankyo, providing access to CRISPR/Cas9 genome editing technology intellectual property for use in its internal research and development.

Horizon Discovery has announced that it will provide access to a novel base editing technology licensed from Rutgers for exclusive use in therapeutic, diagnostic and services applications.

Horizon Discovery has signed a collaboration and license agreement with Mammoth Biosciences, to access Mammoth’s novel CRISPR platform and thereby facilitate delivery of a new generation of genetically engineered CHO cells for the production of biotherapeutics.

Evonetix has announced it has partnered with imec to increase the production of microelectromechanical systems (MEMS)-based silicon chips, enabling the platform to be manufactured at a commercial scale.

Arbor Bioscience and Curio Genomics have announced an enhanced partnership to deliver a host of additional products and solutions to the plant research and development community.

Thermo Fisher Scientific has launched a workflow solution for fast-growing genotyping labs.